EE498 Economic Evaluation of Nanoparticle Albumin-Bound paclitaxel for Previously Treated Advanced NSCLC in Japan

This study aimed to assess the cost-effectiveness of nab-paclitaxel compared with docetaxel from the Japanese payer ’s perspective.

Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: Y. Fukui, W. Chen, T. Maeda, K. Morimoto, K. Moriwaki, K. Shimozuma Source Type: research